Cargando…

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study

BACKGROUND: The presence of autoantibodies in the serum of cancer patients has been associated with immune‐checkpoint inhibitor (ICI) therapy response and immune‐related adverse events (irAEs). A prospective evaluation of different autoantibodies in different cancer entities is missing. MATERIALS AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barth, Dominik A., Stanzer, Stefanie, Spiegelberg, Jasmin, Bauernhofer, Thomas, Absenger, Gudrun, Posch, Florian, Lipp, Rainer, Halm, Michael, Szkandera, Joanna, Balic, Marija, Gerger, Armin, Smolle, Maria A., Hutterer, Georg C., Klec, Christiane, Jost, Philipp J., Kargl, Julia, Stradner, Martin, Pichler, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385593/ https://www.ncbi.nlm.nih.gov/pubmed/35297215 http://dx.doi.org/10.1002/cam4.4675

Ejemplares similares

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
por: Barth, Dominik A., et al.
Publicado: (2022)

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients
por: Terbuch, Angelika, et al.
Publicado: (2018)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
por: Pehserl, Anna-Maria, et al.
Publicado: (2016)

Long-term cardiovascular complications in stage I seminoma patients
por: Terbuch, A., et al.
Publicado: (2017)

Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up
por: Fluhrer, Hannah, et al.
Publicado: (2022)

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors
por: Bezan, Angelika, et al.
Publicado: (2017)

Immune Aging and Immunotherapy in Cancer
por: Kaiser, Melanie, et al.
Publicado: (2021)

MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response
por: Prinz, Felix, et al.
Publicado: (2022)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
por: Brcic, Luka, et al.
Publicado: (2018)

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
por: Riedl, Jakob M., et al.
Publicado: (2020)

MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive Review
por: Smolle, Maria Anna, et al.
Publicado: (2017)

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery
por: Egger, Valentina, et al.
Publicado: (2023)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma
por: Smolle, Maria A, et al.
Publicado: (2021)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

Hedgehog Signaling Pathway in Ovarian Cancer
por: Szkandera, Joanna, et al.
Publicado: (2013)

Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial
por: Riedl, Jakob M., et al.
Publicado: (2021)

Long Non-Coding RNA PANTR1 is Associated with Poor Prognosis and Influences Angiogenesis and Apoptosis in Clear-Cell Renal Cell Cancer
por: Seles, Maximilian, et al.
Publicado: (2020)

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
por: Mollnar, S., et al.
Publicado: (2020)

External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
por: Szkandera, Joanna, et al.
Publicado: (2013)

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience
por: Scheipl, Susanne, et al.
Publicado: (2021)

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
por: Szkandera, J, et al.
Publicado: (2013)

Reply: Comment on ‘Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
por: Szkandera, J, et al.
Publicado: (2013)

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
por: Szkandera, Joanna, et al.
Publicado: (2014)

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Current Status of Long Non-Coding RNAs in Human Cancer with Specific Focus on Colorectal Cancer
por: Smolle, Maria, et al.
Publicado: (2014)

Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
por: Stotz, Michael, et al.
Publicado: (2016)

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer
por: Smolle, Maria A., et al.
Publicado: (2017)

Diabetes mellitus is independently associated with adverse clinical outcome in soft tissue sarcoma patients
por: Stelzl, Adrian, et al.
Publicado: (2020)

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
por: Moik, Florian, et al.
Publicado: (2019)

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study
por: Posch, Florian, et al.
Publicado: (2017)

MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms
por: Posch, Florian, et al.
Publicado: (2021)

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients
por: Lembeck, Anna L., et al.
Publicado: (2020)

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy
por: Klöckl, Marie-Christin, et al.
Publicado: (2020)

Serum sclerostin levels in renal cell carcinoma patients with bone metastases
por: Wibmer, C., et al.
Publicado: (2016)

ASCO update: lung cancer
por: Absenger, Gudrun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jn17lhu9j5sn3dfl35mln4gqj3